Hotchkis & Wiley Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,255,000
| Closed | -$8.27M | – | 533 |
|
|
2023
Q2 | $8.27M | Buy |
1,255,000
+223,140
| +22% | +$1.47M | 0.03% | 237 |
|
|
2023
Q1 | $7.01M | Buy |
1,031,860
+56,600
| +6% | +$384K | 0.03% | 277 |
|
|
2022
Q4 | $7.21M | Buy |
975,260
+36,070
| +4% | +$267K | 0.03% | 251 |
|
|
2022
Q3 | $9.28M | Buy |
939,190
+37,460
| +4% | +$370K | 0.04% | 138 |
|
|
2022
Q2 | $9.83M | Sell |
901,730
-10,730
| -1% | -$117K | 0.04% | 141 |
|
|
2022
Q1 | $10.3M | Buy |
912,460
+368,770
| +68% | +$4.17M | 0.03% | 165 |
|
|
2021
Q4 | $8.53M | Buy |
543,690
+284,270
| +110% | +$4.46M | 0.03% | 217 |
|
|
2021
Q3 | $4.45M | Sell |
259,420
-3,880
| -1% | -$66.5K | 0.01% | 355 |
|
|
2021
Q2 | $5.66M | Buy |
263,300
+20,500
| +8% | +$441K | 0.02% | 300 |
|
|
2021
Q1 | $3.65M | Sell |
242,800
-23,690
| -9% | -$356K | 0.01% | 385 |
|
|
2020
Q4 | $3.5M | Buy |
+266,490
| New | +$3.5M | 0.01% | 352 |
|